Merit Financial Group »

Cytomx Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $227k 53k 4.26
2025-09-30 $170k 53k 3.19

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Gwt (IUSG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Merit Financial Group

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
Kynam Capital Management
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics